PDE3B and PRKACA

  • Number of citations of the paper that reports this interaction (PMID 10454575)
  • 57
  • Data Source:
  • HPRD (in vitro, in vivo)

PDE3B

PRKACA

Gene Name phosphodiesterase 3B, cGMP-inhibited protein kinase, cAMP-dependent, catalytic, alpha
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 5 interactors: AKT1 ANKRA2 PRKACA YWHAB YWHAQ 181 interactors: AANAT ABCA1 ACLY ADCY5 ADD1 ADD2 ADRBK1 AKAP13 AKAP14 AKAP8L AKIP1 ANXA7 APC APOBEC3G ASIC1 ASIC3 ATF1 ATP2B1 AURKA BAD BCL2 BRAF CACNA1C CACNB2 CACNG2 CAD CALD1 CAMKK2 CCDC88A CCND1 CDK16 CETN1 CFTR CIITA CLDN3 CLTC CREB1 CREM CSK CUL5 CYP3A4 DMTN DNAJC5 DSP EEF2K EGFR ESR1 ETV1 FOS FXYD1 GABRB3 GABRR1 GAD1 GAD2 GFAP GJA5 GJB1 GMFB GNA13 GNMT GP1BB GRIA1 GRIA4 GSK3A GSK3B GUSB GYS1 HAND1 HAND2 HDAC1 HDAC8 HMGCR HMGN1 HMGN2 HNRNPD HSPD1 IFNAR1 IQGAP1 IRF2 ITCH ITGA2B ITGA4 ITPKA ITPKB ITPR1 ITPR2 KCNH2 KCNJ12 KCNQ1 KLF1 LCK LCP1 LIPE LRP1 MAP2 MAP3K3 MAPT MBP MC4R MEF2D MEP1B MGMT MIP NDRG1 NFKB1 NIN NOLC1 NOS1 NOXA1 NR3C1 NUP85 PARK2 PDC PDE3B PDE4B PDE4D PDPK1 PFKFB1 PFKFB2 PHKA1 PHOX2A PKIA PLIN1 PLN POU2F1 PPP1R10 PPP1R17 PPP1R1B PPP1R8 PPP1R9B PRKAR1A PSEN1 PTBP1 PTPN12 PTPN13 PTPN7 PTPRR RAF1 RANBP9 RAP1A RAP1B RAP1GAP RASGRF1 RASGRP3 RELA RGS10 RGS13 RGS14 RHOA RRAD RSBN1 RYR1 RYR2 SI SIK1 SIK3 SLC2A2 SLC4A4 SLC9A3R2 SNAP25 SNAPIN SPTBN1 SRC STK11 STMN1 STMN2 SYN1 SYN2 TBXA2R TCF3 TH THOP1 TNP1 TNP2 TPH1 TRIP10 UHRF1 VASP VIM VTN WT1
Entrez ID 5140 5566
HPRD ID 03626 03382
Ensembl ID ENSG00000152270 ENSG00000072062
Uniprot IDs A7E2E5 B7ZM37 Q13370 P17612
PDB IDs 1SO2 1SOJ 2GU8 3AGL 3AGM 3AMA 3AMB 3L9L 3L9M 3L9N 3MVJ 3NX8 3OOG 3OVV 3OWP 3OXT 3P0M 3POO 3VQH 4AE6 4AE9
Enriched GO Terms of Interacting Partners?
Tagcloud ?
amounts  analogs  camp  cyclic  decreases  fact  feedback  glp  glucagonlike  hit  igf  immunoprecipitation  inhibits  insulin  islets  mediates  nonhydrolyzable  pancreatic  parallel  phosphodiesterase  secretagogues  secreted  secreting  secretion  stimulate  substrates  t15  turn 
abrogated  advance  amplified  bad  bcl  conferred  discovered  doi  emergence  frame  her2  inactivated  june  lapatinib  onc  oncogene  online  permitting  phosphoinositide  pim1  publication  reading  rescue  rescued  restored  sensitized  trastuzumab  uncover  xl 
Tagcloud (Difference) ?
amounts  analogs  camp  cyclic  decreases  fact  feedback  glp  glucagonlike  hit  igf  immunoprecipitation  inhibits  insulin  islets  mediates  nonhydrolyzable  pancreatic  parallel  phosphodiesterase  secretagogues  secreted  secreting  secretion  stimulate  substrates  t15  turn 
abrogated  advance  amplified  bad  bcl  conferred  discovered  doi  emergence  frame  her2  inactivated  june  lapatinib  onc  oncogene  online  permitting  phosphoinositide  pim1  publication  reading  rescue  rescued  restored  sensitized  trastuzumab  uncover  xl 
Tagcloud (Intersection) ?